Search research articles
Contact Us
Filters
Showing results (511-520 of 547) with videos related to
Page
of 55
Sort By:
Atherosclerosis. Supplements
|
August 29, 2015
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy
Carlos Aguiar, Eduardo Alegria, Riccardo C Bonadonna, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
May 24, 2017
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia
Roberto Ferrari, Carlos Aguiar, Eduardo Alegria, et al.
European Heart Journal
|
January 12, 2005
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
Marcus D Flather, Marcelo C Shibata, Andrew J S Coats, et al.
Internal and Emergency Medicine
|
April 23, 2024
A COVID-19 specific multiparametric and ECG-based score for the prediction of in-hospital mortality: ELCOVID score
Marco Zuin, Roberto Ferrari, Gabriele Guardigli, et al.
JACC. Cardiovascular Interventions
|
May 21, 2013
Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction)
Giampaolo Niccoli, Stefano Rigattieri, Maria Rosaria De Vita, et al.
European Journal of Heart Failure
|
December 28, 2021
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry
Agnieszka Kapłon-Cieślicka, Lina Benson, Ovidiu Chioncel, et al.
European Heart Journal
|
September 3, 2015
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT)
Michel Komajda, Franz Weidinger, Mathieu Kerneis, et al.
Journal of Hypertension
|
December 16, 2010
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals
Jasper J Brugts, Aaron Isaacs, Moniek Pm de Maat, et al.
European Journal of Preventive Cardiology
|
May 12, 2023
Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry
Ovidiu Chioncel, Lina Benson, Maria G Crespo-Leiro, et al.
European Journal of Heart Failure
|
December 22, 2019
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry
Mitja Lainščak, Ivan Milinković, Marija Polovina, et al.
Page
of 55
Search research articles
Search
Showing results (511-520 of 547) with videos related to
Sort By:
Page
of 55
Atherosclerosis. Supplements
|
August 29, 2015
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy
Carlos Aguiar, Eduardo Alegria, Riccardo C Bonadonna, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
May 24, 2017
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia
Roberto Ferrari, Carlos Aguiar, Eduardo Alegria, et al.
European Heart Journal
|
January 12, 2005
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
Marcus D Flather, Marcelo C Shibata, Andrew J S Coats, et al.
Internal and Emergency Medicine
|
April 23, 2024
A COVID-19 specific multiparametric and ECG-based score for the prediction of in-hospital mortality: ELCOVID score
Marco Zuin, Roberto Ferrari, Gabriele Guardigli, et al.
JACC. Cardiovascular Interventions
|
May 21, 2013
Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction)
Giampaolo Niccoli, Stefano Rigattieri, Maria Rosaria De Vita, et al.
European Journal of Heart Failure
|
December 28, 2021
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry
Agnieszka Kapłon-Cieślicka, Lina Benson, Ovidiu Chioncel, et al.
European Heart Journal
|
September 3, 2015
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT)
Michel Komajda, Franz Weidinger, Mathieu Kerneis, et al.
Journal of Hypertension
|
December 16, 2010
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals
Jasper J Brugts, Aaron Isaacs, Moniek Pm de Maat, et al.
European Journal of Preventive Cardiology
|
May 12, 2023
Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry
Ovidiu Chioncel, Lina Benson, Maria G Crespo-Leiro, et al.
European Journal of Heart Failure
|
December 22, 2019
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry
Mitja Lainščak, Ivan Milinković, Marija Polovina, et al.
Page
of 55